At the news
? BEARISHIMPACT 6/10 8-K filed Apr 13, 2026 at 07:10 ET
ImageneBio is raising $30 million through a private placement of pre-funded warrants, which allows investors to purchase common stock at a nominal exercise price. The company will use the proceeds for late-phase development in atopic dermatitis and expansion into alopecia areata. This constitutes a dilutive capital raise during a period of financial stress.
- ImageneBio is raising $30 million through a private placement of pre-funded warrants
- The warrants are priced at $5.199 per share with a nominal exercise price of $0.001
- Proceeds will fund late-phase development in atopic dermatitis and expansion into alopecia areata
- The transaction represents significant dilution to existing shareholders
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access